Organisation paid for research Program year 2023 Source: CMS Open Payments

Allnce Uro Spec

Neither a doctor nor a teaching hospital

Research payments

$29,141

5 payments

Through program year 2023, Allnce Uro Spec is reported as receiving $29,141 in research payments, across 5 payments.

By program year

2 rows
Year Kind Amount Payments
2023 Research $11,097 1
2019 Research $18,044 4

Breakdown

Who paid Research payments · program years 2019–2023
  1. Janssen Research & Development, LLC $29,141 5 payments
Studies the money was for Research payments · program years 2019–2023
  1. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study of ARN-509 in Men With Non-Metastatic (M0) Castration-Resistant Prostate Cancer $18,044 4 payments
  2. A Multi Center Randomized Double Blind Placebo Controlled Phase III Study of ARN509 in Men With Non Metastatic M0 Castration Resistant Prostate Cancer $11,097 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record